Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.
Investors are assessing China's instant retaliation to Trump's additional tariffs, amid worries about the risk of a trade war.
Investing.com -- Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% ...
2d
InvestorsHub on MSNModerna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s NominationThe U.S. Senate Finance Committee has voted to advance Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
Check the time stamp on this data. Updated AI-Generated Signals for Biontech Se (BNTX) available here: BNTX. Type a few ...
BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...
Investing.com - Healthcare and vaccine stocks are likely to be in the spotlight on Wednesday as Robert F. Kennedy Jr., U.S.
Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you ... last year compared to 25.6% for the S&P 500 -- a difference of -15.0% BNTX has an average ...
PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results